HHS Orders Gallo Forum Canceled; Meeting May Be Held After OSI report final – Calabresi
In Brief: NY Judges, Lawyers Form Breast Cancer Alert; Terms of ODAC Chairman, 3 Members Expire
Breast Cancer Vs. Other Cancers In Budget Showdown
ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin
Management Survey Finds Problems At ACS, Advises Change
Coalition On Smoking Or Health to Launch Effort at $5 Tax Increase
DCBDC Advisors Okay New Program In Breast Cancer
Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- CBER Director Vinay Prasad dared to “say no to drugs”
- J. Craig Venter’s work was foundational to cancer advancement of the past 25 years









